The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Rite Aid Corp

NYSE: RAD
Last

(U.S.) $7.41

Today's change+0.15 +2.07%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Rite Aid Corp

NYSE: RAD
Last

(U.S.) $7.41

Today's change+0.15 +2.07%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Rite Aid Corp Hits New 100-day High

Rite Aid Corp closed up sharply Friday, rallying (U.S.)$0.15 or 2.07% to (U.S.)$7.41 and setting a new 100-day high. Over the last five days, shares have gained 9.45% and 46.44% year to date. Shares have outperformed the S&P 500 by 29.93% during the last year.

Key company metrics

  • Open(U.S.) $7.29
  • Previous close(U.S.) $7.26
  • High(U.S.) $7.49
  • Low(U.S.) $7.26
  • Bid / Ask-- / --
  • YTD % change+46.44%
  • Volume24,663,279
  • Average volume (10-day)40,257,404
  • Average volume (1-month)24,333,125
  • Average volume (3-month)23,081,576
  • 52-week range(U.S.) $4.42 to (U.S.) $8.62
  • Beta1.64
  • Trailing P/E22.54×
  • P/E 1 year forward21.09×
  • Forward PEG0.53×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.33
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.10%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedNov 29, 201411/29/2014Aug 30, 201408/30/2014May 31, 201405/31/2014Mar 01, 201403/01/2014
Revenue6,6926,5236,4666,597
Total other revenue--------
Total revenue6,6926,5236,4666,597
Gross profit1,9231,8951,8031,886
Total cost of revenue4,7694,6284,6634,712
Total operating expense6,4896,2766,3126,446
Selling / general / administrative1,6921,6411,6441,717
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)277517
Other operating expenses, total--------
Operating income204247154152
Interest income (expense), net non-operating-97-101-101-102
Gain (loss) on sale of assets0200
Other--------
Income before tax1071485349
Income after tax1051284155
Income tax, total22012-6
Net income1051284155
Total adjustments to net income0000
Net income before extra. items1051284155
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1051284155
Inc. avail. to common incl. extra. items1051284155
Diluted net income1051294361
Dilution adjustment--115
Diluted weighted average shares1,0201,0221,0201,058
Diluted EPS excluding extraordinary itemsvalue per share0.100.130.040.06
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.130.130.050.07